Literature DB >> 15273113

Nitric oxide generated from isoniazid activation by KatG: source of nitric oxide and activity against Mycobacterium tuberculosis.

Graham S Timmins1, Sharon Master, Frank Rusnak, Vojo Deretic.   

Abstract

Isonicotinic acid hydrazide (INH) is a frontline antituberculosis agent. Once taken up by Mycobacterium tuberculosis, INH requires activation by the catalase-peroxidase KatG, converting INH from its prodrug form into a range of bactericidal reactive species. Here we used 15N-labeled INH together with electron paramagnetic resonance spin trapping techniques to demonstrate that nitric oxide (NO*) is generated from oxidation at the hydrazide nitrogens during the activation of INH by M. tuberculosis KatG. We also observed that a specific scavenger of NO* provided protection against the antimycobacterial activity of INH in bacterial culture. No significant increases in mycobacterial protein nitration were detected, suggesting that NOdot; and not peroxynitrite, a nitrating metabolite of NO*, is involved in antimycobacterial action. In conclusion, INH-derived NO* has biological activity, which directly contributes to the antimycobacterial action of INH.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15273113      PMCID: PMC478481          DOI: 10.1128/AAC.48.8.3006-3009.2004

Source DB:  PubMed          Journal:  Antimicrob Agents Chemother        ISSN: 0066-4804            Impact factor:   5.191


  32 in total

1.  Mycobacterium tuberculosis KatG is a peroxynitritase.

Authors:  N L Wengenack; M P Jensen; F Rusnak; M K Stern
Journal:  Biochem Biophys Res Commun       Date:  1999-03-24       Impact factor: 3.575

Review 2.  The genetics and biochemistry of isoniazid resistance in mycobacterium tuberculosis.

Authors:  R A Slayden; C E Barry
Journal:  Microbes Infect       Date:  2000-05       Impact factor: 2.700

3.  Inhibitory effect of NO-releasing ciprofloxacin (NCX 976) on Mycobacterium tuberculosis survival.

Authors:  R Ciccone; F Mariani; A Cavone; T Persichini; G Venturini; E Ongini; V Colizzi; M Colasanti
Journal:  Antimicrob Agents Chemother       Date:  2003-07       Impact factor: 5.191

4.  Overexpression of inhA, but not kasA, confers resistance to isoniazid and ethionamide in Mycobacterium smegmatis, M. bovis BCG and M. tuberculosis.

Authors:  Michelle H Larsen; Catherine Vilchèze; Laurent Kremer; Gurdyal S Besra; Linda Parsons; Max Salfinger; Leonid Heifets; Manzour H Hazbon; David Alland; James C Sacchettini; William R Jacobs
Journal:  Mol Microbiol       Date:  2002-10       Impact factor: 3.501

5.  Horseradish peroxidase catalyzed nitric oxide formation from hydroxyurea.

Authors:  Jinming Huang; Erin M Sommers; Daniel B Kim-Shapiro; S Bruce King
Journal:  J Am Chem Soc       Date:  2002-04-03       Impact factor: 15.419

6.  Evidence for isoniazid-dependent free radical generation catalyzed by Mycobacterium tuberculosis KatG and the isoniazid-resistant mutant KatG(S315T).

Authors:  N L Wengenack; F Rusnak
Journal:  Biochemistry       Date:  2001-07-31       Impact factor: 3.162

7.  The inducible nitric oxide synthase locus confers protection against aerogenic challenge of both clinical and laboratory strains of Mycobacterium tuberculosis in mice.

Authors:  C A Scanga; V P Mohan; K Tanaka; D Alland; J L Flynn; J Chan
Journal:  Infect Immun       Date:  2001-12       Impact factor: 3.441

8.  Fast-flow EPR spectroscopic observation of the isoniazid, iproniazid, and phenylhydrazine hydrazyl radicals.

Authors:  Herbert J Sipe; Adrian R Jaszewski; Ronald P Mason
Journal:  Chem Res Toxicol       Date:  2004-02       Impact factor: 3.739

9.  Oxidative stress response genes in Mycobacterium tuberculosis: role of ahpC in resistance to peroxynitrite and stage-specific survival in macrophages.

Authors:  S S Master; B Springer; P Sander; E C Boettger; V Deretic; G S Timmins
Journal:  Microbiology       Date:  2002-10       Impact factor: 2.777

10.  Oxidative stress increases susceptibility of Mycobacterium tuberculosis to isoniazid.

Authors:  Vanja M Bulatovic; Nancy L Wengenack; James R Uhl; Leslie Hall; Glenn D Roberts; Franklin R Cockerill; Frank Rusnak
Journal:  Antimicrob Agents Chemother       Date:  2002-09       Impact factor: 5.191

View more
  14 in total

1.  A novel mechanism of growth phase-dependent tolerance to isoniazid in mycobacteria.

Authors:  Makoto Niki; Mamiko Niki; Yoshitaka Tateishi; Yuriko Ozeki; Teruo Kirikae; Astrid Lewin; Yusuke Inoue; Makoto Matsumoto; John L Dahl; Hisashi Ogura; Kazuo Kobayashi; Sohkichi Matsumoto
Journal:  J Biol Chem       Date:  2012-05-30       Impact factor: 5.157

Review 2.  Does Concurrent Use of Some Botanicals Interfere with Treatment of Tuberculosis?

Authors:  William R Folk; Aaron Smith; Hailong Song; Dennis Chuang; Jianlin Cheng; Zezong Gu; Grace Sun
Journal:  Neuromolecular Med       Date:  2016-05-07       Impact factor: 3.843

Review 3.  The future for early-stage tuberculosis drug discovery.

Authors:  Edison S Zuniga; Julie Early; Tanya Parish
Journal:  Future Microbiol       Date:  2015       Impact factor: 3.165

4.  Mycobacterium tuberculosis dihydrofolate reductase is not a target relevant to the antitubercular activity of isoniazid.

Authors:  Feng Wang; Paras Jain; Gulcin Gulten; Zhen Liu; Yicheng Feng; Krishna Ganesula; Alifiya S Motiwala; Thomas R Ioerger; David Alland; Catherine Vilchèze; William R Jacobs; James C Sacchettini
Journal:  Antimicrob Agents Chemother       Date:  2010-06-21       Impact factor: 5.191

Review 5.  Isoniazid and host immune system interactions: A proposal for a novel comprehensive mode of action.

Authors:  Saifur R Khan; Yousef Manialawy; Arno G Siraki
Journal:  Br J Pharmacol       Date:  2019-11-12       Impact factor: 8.739

6.  Molecular and physiological effects of mycobacterial oxyR inactivation.

Authors:  Eileen Pagán-Ramos; Sharon S Master; Christopher L Pritchett; Renate Reimschuessel; Michele Trucksis; Graham S Timmins; Vojo Deretic
Journal:  J Bacteriol       Date:  2006-04       Impact factor: 3.490

7.  Resistance to first-line anti-TB drugs is associated with reduced nitric oxide susceptibility in Mycobacterium tuberculosis.

Authors:  Jonna Idh; Mekidim Mekonnen; Ebba Abate; Wassihun Wedajo; Jim Werngren; Kristian Ängeby; Maria Lerm; Daniel Elias; Tommy Sundqvist; Abraham Aseffa; Olle Stendahl; Thomas Schön
Journal:  PLoS One       Date:  2012-06-29       Impact factor: 3.240

8.  Nitric Oxide-Dependent Electron Transport Chain Inhibition by the Cytochrome bc1 Inhibitor and Pretomanid Combination Kills Mycobacterium tuberculosis.

Authors:  Sheng Zeng; Jingran Zhang; Mingwei Sun; Xiaofei Zhang; Gregory M Cook; Tianyu Zhang
Journal:  Antimicrob Agents Chemother       Date:  2021-08-17       Impact factor: 5.191

9.  Isoniazid inhibits the heme-based reactivity of Mycobacterium tuberculosis truncated hemoglobin N.

Authors:  Paolo Ascenzi; Andrea Coletta; Yu Cao; Viviana Trezza; Loris Leboffe; Gabriella Fanali; Mauro Fasano; Alessandra Pesce; Chiara Ciaccio; Stefano Marini; Massimo Coletta
Journal:  PLoS One       Date:  2013-08-01       Impact factor: 3.240

Review 10.  Proteome turnover in bacteria: current status for Corynebacterium glutamicum and related bacteria.

Authors:  Christian Trötschel; Stefan P Albaum; Ansgar Poetsch
Journal:  Microb Biotechnol       Date:  2013-02-20       Impact factor: 5.813

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.